pharmaphorum
JANUARY 9, 2022
US medical device company Abbott has said it plans to launch a new range of ‘biowearable’ health devices aimed at consumers, in a move that builds on its expertise in glucose monitoring. The company’s chief executive – Robert Ford – made the announcement at the massive CES tech trade show in Las Vegas, a venue usually dedicated to new TVs, gaming equipment, new smartphones and the like.
Outsourcing Pharma
JANUARY 12, 2022
The company plans to launch a Phase Ib/II study of its compound NVG-291 in collaboration with researchers at Northwestern Universityâs Shirley Ryan AbilityLab.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Healthcare
JANUARY 10, 2022
Investors poured record-breaking $29.1B into digital health startups. Will the momentum continue in 2022? hlandi. Mon, 01/10/2022 - 12:17.
Pharma Mirror
JANUARY 14, 2022
Amsterdam, CPhI Worldwide – the world’s largest pharma event, which will be hosted at the Frankfurt Messe (1-3 November, 2022) – releases the final part of its annual report with far reaching predictions for 2022 and beyond into 2025 for the nutraceuticals market. The findings explore the long-term trends underway in the global nutraceutical industry, with consumers predicted to increase spending on natural products and sustainable formulations that can offer ‘preventative or proactive’ health b
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
JANUARY 11, 2022
With evidence growing that the current crop of COVID-19 vaccines are less protective against infection with Omicron, both Pfizer and Moderna have announced plans to develop new versions of their mRNA-based shots that are tailored to the new variant. Pfizer has said that a COVID-19 jab specifically targeting Omicron, as well as other existing variants, will begin human trials later this month and could be available as early as March.
Outsourcing Pharma
JANUARY 10, 2022
Joining with a noted research foundation, the group is aiming for earlier detection and treatment of the disease, which hits nearly 500K people annually.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharma Tutor
JANUARY 13, 2022
Inauguration of Pharmacy Council of India: First step in Implementation of Pharmacy Act, 1948. About Authors. Dr. R. S. Thakur. Chief Editor, Journal of Pharmaceutical Research. Krupanidhi College of Pharmacy, Bengaluru-560035. Email: drramsthakur@gmail.com. admin. Thu, 01/13/2022 - 17:31. Tags. Articles.
pharmaphorum
JANUARY 14, 2022
The European Commission, EMA and national regulators within the EU have launched an initiative to change the way clinical trials are designed and run in order to position the bloc as an international “focal point” for clinical research. The broad strokes of the proposals are laid out in a document entitled Accelerating Clinical Trials in the EU (ACT EU) that lists priority actions that will be taken, including measures to allow greater use of innovative clinical trial designs.
Outsourcing Pharma
JANUARY 13, 2022
With the amount of available data increasing and technology evolving, says a company leader, the job of data manager is more demanding than ever before.
Fierce Healthcare
JANUARY 10, 2022
Facing understaffed hospitals, California temporarily allows asymptomatic workers to return after positive COVID test, exposure. dmuoio. Mon, 01/10/2022 - 13:27.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Druggist
JANUARY 12, 2022
Product Image (name: product-image)Product Image (name: product-image)Product Image (name: product-image)Product Image (name: product-image)Product Image (name: product-image)Product Image (name: product-image)Product Image (name: product-image)Product Image (name: product-image). The post Product Image (name: product-image) appeared first on Druggist.Online.
pharmaphorum
JANUARY 12, 2022
Roche has launched what it says is a first-of-its kind handheld glucose management device, backed up by a digital platform that aims to simplify the work of doctors and nurses as they deliver care to patients. The cobas pulse system is a point-of-care device that combines a glucose test strip reader with a touch screen that is used for displaying patient information and data, as well as analysing and sharing clinical results.
Outsourcing Pharma
JANUARY 14, 2022
The World Health Organization has recommended the drugs for COVID-19 patients, broadening the range of therapies to combat the virus behind the pandemic.
Fierce Healthcare
JANUARY 10, 2022
JPM 2022: Aledade scoops up advance care planning startup Iris Healthcare to build out health services unit. hlandi. Mon, 01/10/2022 - 20:53.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
indispensable health
JANUARY 11, 2022
Indispensable Health Employee Interview. “ My Name is Stephanie Everard and I am a Pharmacist Team Member with Indispensable Health ” — Stephanie Everard, PharmD. Stephanie, when did you become interested in pharmacy? I became interested in pharmacy in high school. I spent time working in a community pharmacy and a compounding pharmacy.
pharmaphorum
JANUARY 14, 2022
Japanese pharma group Otsuka has led a $10 million first-round financing of GrayMatters Health, an Israeli company developing a digital health approach to the management of mental illness. Otsuka Medical Devices is also taking some rights to GrayMatters’ platform – called Prism – in Japan and some other Asian countries in connection with the financing, which was supported by Joy Ventures, J-Ventures, J-Impact, and existing backers Marius Nacht and Joyance Ventures.
Outsourcing Pharma
JANUARY 12, 2022
The pharma firm and collaborator Molecular Partners reported positive data out of their Phase II study for ensovibep, an antiviral for treating the virus.
Fierce Healthcare
JANUARY 13, 2022
Express Scripts, Columbia study finds pharmacists taking greater role in patient care. pminemyer. Thu, 01/13/2022 - 13:06.
Pharma Marketing Network
JANUARY 11, 2022
Pharma USA 2022 is North America’s leading commercial pharma event. Here is where we will witness the moment where pharma will learn to self-disrupt. The opportunity to redefine what an industry means doesn’t come around often. For pharma, that moment is now. It’s time to lead the overhaul of our broken healthcare system to one that is fit-for-purpose.
pharmaphorum
JANUARY 13, 2022
In 2020, over half of total spending on brand medicines went to the supply chain, middlemen and other stakeholders, overtaking the amount going to drug manufacturers for the first time, according to a new study. The report from Berkeley Research Group (BRG) – which was funded by the pharma industry trade group PhRMA – reveals a steady decrease in the proportion received by drugmakers from around 67% in 2013 to 49.5% in 2020.
Outsourcing Pharma
JANUARY 13, 2022
Performance Cell Manufacturing, a CDMO with a focus on manufacturing cell therapies, has been acquired by Great Point Partners and will now operate under the name Cellipont Bioservices.
Fierce Healthcare
JANUARY 12, 2022
JPM22, Day 3: Signify Health rolls out partnership program, BCBS Massachusetts exec talks tackling health inequity and more. hlandi. Wed, 01/12/2022 - 08:11.
Impact Pharmaceutical Services
JANUARY 10, 2022
January 10, 2022 | Julia DiFiore, PhD | Clinical Research Scientist I | Regulatory Affairs Many of us involved with drug development derive a lot of satisfaction in knowing that our work contributes to improving the health of patients around the globe. We offer our insight and expertise to design studies, analyze the results, and […].
pharmaphorum
JANUARY 12, 2022
The development of gene therapies for Duchenne muscular dystrophy has proved to be challenging, but one of the key players – Sarepta – thinks it may have the clinical data needed to file for regulator approval. The new data from the mid-stage Study 102 of SRP-9001 (delandistrogene moxeparvovec) comes from 21 patients who were initially in the placebo group of the study but crossed over to receive the gene therapy later.
Pharma Mirror
JANUARY 10, 2022
Speaking, hearing, and comprehending is how most of us communicate with the outside world, and being unable to do so — or even to do so with difficulty — can be a significant impediment to dealing with others. In particular, communications disorders can be a major challenge to school-age children, who might struggle to reach their full potential or even get the most out of their schooling.
Fierce Healthcare
JANUARY 10, 2022
Insurers must cover at-home COVID-19 tests starting Jan. 15 under new CMS directive. rking. Mon, 01/10/2022 - 16:18.
Impact Pharmaceutical Services
JANUARY 10, 2022
RESEARCH TRIANGLE PARK, NC: January 10, 2022 – In October 2021, Jeff Golden, was promoted to the position of Senior Director, Regulatory Services at Impact Pharmaceutical Services, Inc. (IMPACT). Since joining IMPACT in 2016, Jeff has been a driving force in shaping the direction and growth of the Regulatory Services Department at IMPACT. Jeff has […].
pharmaphorum
JANUARY 12, 2022
Prospects for Aldeyra’s dry eye disease candidate reproxalap were hit last month after the drug failed to hit its primary objective in a phase 3 trial, but the company isn’t giving up and has new data showing an improvement over Novartis rival therapy Xiidra. Patients treated with reproxalap reported significantly less eye discomfort and itching than those using Xiidra (lifitegrast) in the new phase 2 trial, which Aldeyra said backs up early tolerability comparisons between the drugs
Outsourcing Pharma
JANUARY 10, 2022
Life science investor group, Novo Holdings, has agreed to buy Ritedose, the largest sterile CDMO in the US focused on advanced blow-fill-seal technology, from Hong-Kong based, AGIC Capital, and Chinaâs Humanwell.
Fierce Healthcare
JANUARY 10, 2022
JPM22: Teladoc projects $2.03B in 2021 revenue, up from previous guidance, after stock plummeted last year. rtorrence. Mon, 01/10/2022 - 10:54.
Pharma Mirror
JANUARY 10, 2022
Southampton, UK: Synairgen plc (LSE: SNG), the respiratory company developing SNG001 (inhaled interferon-beta or IFN-beta) for the treatment of COVID-19 as potentially the first host-targeted, broad-spectrum antiviral treatment delivered directly into the lungs, today announces a partnership with global experts in strategic engagement and commercialisation, Ashfield Engage.
pharmaphorum
JANUARY 12, 2022
EMA “lags behind” other international regulators when it comes to approval timelines, finds EFPIA analysis. Only a regulatory framework that “embraces a culture of excellence and innovation” will make Europe a world leader in life sciences and ensure people can reap the benefits of life-changing new treatments. That’s according to the EFPIA’s analysis of the region’s regulatory framework, which compares the timelines of national regulatory agencies, and suggests key areas for change as the Europ
Outsourcing Pharma
JANUARY 14, 2022
According to the companyâs 12th Annual Pharmaceutical Innovation Report, pharmaceutical R&D return on investment has climbed to its highest peak since 2014.
Fierce Healthcare
JANUARY 11, 2022
JPM 2022: CVS Health boosts 2021 guidance on back of stronger than expected retail performance in Q4. pminemyer. Tue, 01/11/2022 - 09:06.
Expert insights. Personalized for you.
145 
Let's personalize your content